Target intelligence / Profile preview

Plasmodium falciparum mitochondrial electron transport chain and redox system (Pf-mETC/Redox)

Target
Pf-mETC/Redox
Molecular classification
Enzyme, Mitochondrial respiratory chain, Oxidoreductase
01

Overview

The Plasmodium falciparum mitochondrial electron transport chain (mETC) and redox system are essential for the parasite's survival and its transmission from humans to mosquitoes (Nixon et al., 2013). In the asexual blood stages, the mETC primarily functions to provide electrons for dihydroorotate dehydrogenase (DHODH), which is required for de novo pyrimidine biosynthesis (Sheokand et al., 2024). However, during the development of gametocytes—the sexual stages of the parasite—the mitochondria undergo a significant metabolic shift, becoming more active and relying on oxidative phosphorylation for ATP production (MacRae et al., 2013). This transition involves the upregulation of respiratory complexes and the development of mitochondrial cristae, making the system a vulnerable target for transmission-blocking interventions (Evers et al., 2021). Key components include the cytochrome bc1 complex (Complex III), NADH dehydrogenase 2 (NDH2), and various antioxidant enzymes that protect the parasite from oxidative damage (Müller et al., 2004). Drugs like atovaquone and experimental inhibitors like endochin-like quinolones (ELQs) target these pathways, exploiting structural differences between the parasite and human mitochondrial machinery to achieve selective toxicity (Nixon et al., 2013).

Other names
Plasmodium falciparum mitochondrial respiratory chainPf-mETCPlasmodium falciparum mitochondrial redox systemPf-mtETCPlasmodium falciparum gametocyte mitochondria
02

Mechanism of action

Inhibition of the cytochrome bc1 complex, inhibition of dihydroorotate dehydrogenase, inhibition of NADH dehydrogenase 2, disruption of mitochondrial membrane potential, and induction of oxidative stress.

03

Biological functions

Energy productionPyrimidine biosynthesisRedox homeostasisOxidative phosphorylationATP synthesis
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance (especially mutations in cytochrome b)Hemolytic anemia in G6PD-deficient patients (for redox-active drugs)Selectivity challenges to avoid host mitochondrial toxicity
06

Interacting drugs

Atovaquone

7 more in the full profile.

07

Biomarkers

Cytochrome b mutations (e.g., Y268S, Y268N)Dihydroorotate dehydrogenase mutations

Beyond the preview

Go deeper on Plasmodium falciparum mitochondrial electron transport chain and redox system (Pf-mETC/Redox).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum mitochondrial electron transport chain and redox system (Pf-mETC/Redox).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call